Kingdom providers review medical history, risk factors, and goals before initiating treatment and continue monitoring throughout care
Under recent legislation, out-of-pocket drug costs are capped annually, which may help with expensive medications
Targeting innate immune mediators in type 1 and type 2 diabetes
First-time prescribing of ADMs decreased slightly in March 2025 relative to December (-6.56%), while first-time prescribing of AOMs increased from December 2024 to January 2025, before remaining relatively stable until March 2025 (+18.63%)
Thank you, Nuvo, for showing me that I could do it
Pharmaceutical giant Novo Nordisk, which produces Ozempic and Wegovy, currently dominates the market, though theyve faced supply shortages in recent months due to an increased demand